Karlsen TH - Search Results

1

Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.

Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg Ø, Karlsen TH. Hov JR, et al. Among authors: karlsen th. Liver Int. 2017 Mar;37(3):458-465. doi: 10.1111/liv.13238. Epub 2016 Sep 13. Liver Int. 2017. PMID: 27558072

2

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM. Bowlus CL, et al. Among authors: karlsen th. J Hepatol. 2006 Nov;45(5):704-10. doi: 10.1016/j.jhep.2006.03.012. Epub 2006 Apr 25. J Hepatol. 2006. PMID: 16750586

3

Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.

Karlsen TH, Lie BA, Frey Frøslie K, Thorsby E, Broomé U, Schrumpf E, Boberg KM. Karlsen TH, et al. Gastroenterology. 2006 Sep;131(3):781-7. doi: 10.1053/j.gastro.2006.05.057. Gastroenterology. 2006. PMID: 16952547

4

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Karlsen TH, et al. Am J Gastroenterol. 2007 Jan;102(1):115-21. doi: 10.1111/j.1572-0241.2006.00928.x. Epub 2006 Nov 13. Am J Gastroenterol. 2007. PMID: 17100974

5

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. Karlsen TH, et al. J Hepatol. 2007 May;46(5):899-906. doi: 10.1016/j.jhep.2007.01.032. Epub 2007 Feb 27. J Hepatol. 2007. PMID: 17383044

6

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.

Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA. Melum E, et al. Among authors: karlsen th. Hepatology. 2008 Jan;47(1):90-6. doi: 10.1002/hep.21964. Hepatology. 2008. PMID: 18023027

7

An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis.

Melum E, Karlsen TH, Bergquist A, Schrumpf E, Boberg KM. Melum E, et al. Among authors: karlsen th. Am J Gastroenterol. 2008 Apr;103(4):1045; author reply 1045-6. doi: 10.1111/j.1572-0241.2007.01772_5.x. Am J Gastroenterol. 2008. PMID: 18397431 No abstract available.

8

Gallbladder polyps in primary sclerosing cholangitis: not so benign.

Karlsen TH, Schrumpf E, Boberg KM. Karlsen TH, et al. Curr Opin Gastroenterol. 2008 May;24(3):395-9. doi: 10.1097/MOG.0b013e3282f5727a. Curr Opin Gastroenterol. 2008. PMID: 18408471 Review.

9

Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma.

Forsbring M, Vik ES, Dalhus B, Karlsen TH, Bergquist A, Schrumpf E, Bjørås M, Boberg KM, Alseth I. Forsbring M, et al. Among authors: karlsen th. Carcinogenesis. 2009 Jul;30(7):1147-54. doi: 10.1093/carcin/bgp118. Epub 2009 May 14. Carcinogenesis. 2009. PMID: 19443904 Free PMC article.

10

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF. Lorentzen AR, et al. Among authors: karlsen th. Ann Neurol. 2009 Jun;65(6):658-66. doi: 10.1002/ana.21695. Ann Neurol. 2009. PMID: 19630074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters